Corporate1% match
New Alzheimer's Drug Deemed 'Surprisingly Tolerable' by Public Trial Participants
Researchers Note Preliminary Findings Suggest Users Still Exhibit Basic Signs of Life and Occasional Lucidity, Exceeding Internal Projections.
Aug 8, 2026



